These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

239 related items for PubMed ID: 32462970

  • 1. Identification of potential inhibitors of SARS-COV-2 endoribonuclease (EndoU) from FDA approved drugs: a drug repurposing approach to find therapeutics for COVID-19.
    Chandra A, Gurjar V, Qamar I, Singh N.
    J Biomol Struct Dyn; 2021 Aug; 39(12):4201-4211. PubMed ID: 32462970
    [Abstract] [Full Text] [Related]

  • 2. Identification of promising antiviral drug candidates against non-structural protein 15 (NSP15) from SARS-CoV-2: an in silico assisted drug-repurposing study.
    Khan RJ, Jha RK, Singh E, Jain M, Amera GM, Singh RP, Muthukumaran J, Singh AK.
    J Biomol Struct Dyn; 2022 Jan; 40(1):438-448. PubMed ID: 32885740
    [Abstract] [Full Text] [Related]

  • 3. In silico validation of coumarin derivatives as potential inhibitors against Main Protease, NSP10/NSP16-Methyltransferase, Phosphatase and Endoribonuclease of SARS CoV-2.
    Maurya AK, Mishra N.
    J Biomol Struct Dyn; 2021 Nov; 39(18):7306-7321. PubMed ID: 32835632
    [Abstract] [Full Text] [Related]

  • 4. In silico prediction of potential inhibitors for the main protease of SARS-CoV-2 using molecular docking and dynamics simulation based drug-repurposing.
    Kumar Y, Singh H, Patel CN.
    J Infect Public Health; 2020 Sep; 13(9):1210-1223. PubMed ID: 32561274
    [Abstract] [Full Text] [Related]

  • 5. High-throughput screening of the ReFRAME, Pandemic Box, and COVID Box drug repurposing libraries against SARS-CoV-2 nsp15 endoribonuclease to identify small-molecule inhibitors of viral activity.
    Choi R, Zhou M, Shek R, Wilson JW, Tillery L, Craig JK, Salukhe IA, Hickson SE, Kumar N, James RM, Buchko GW, Wu R, Huff S, Nguyen TT, Hurst BL, Cherry S, Barrett LK, Hyde JL, Van Voorhis WC.
    PLoS One; 2021 Sep; 16(4):e0250019. PubMed ID: 33886614
    [Abstract] [Full Text] [Related]

  • 6. Repurposing approved drugs as inhibitors of SARS-CoV-2 S-protein from molecular modeling and virtual screening.
    de Oliveira OV, Rocha GB, Paluch AS, Costa LT.
    J Biomol Struct Dyn; 2021 Jul; 39(11):3924-3933. PubMed ID: 32448085
    [Abstract] [Full Text] [Related]

  • 7. Prediction of potential inhibitors against SARS-CoV-2 endoribonuclease: RNA immunity sensing.
    Al-Rashedi NAM, Munahi MG, Ah ALObaidi L.
    J Biomol Struct Dyn; 2022 Jul; 40(11):4879-4892. PubMed ID: 33357040
    [Abstract] [Full Text] [Related]

  • 8. Inhibition of SARS-CoV-2 NSP-15 by Uridine-5'-Monophosphate Analogues Using QSAR Modelling, Molecular Dynamics Simulations, and Free Energy Landscape.
    Alshahrani MM.
    Saudi Pharm J; 2024 Jan; 32(1):101914. PubMed ID: 38111672
    [Abstract] [Full Text] [Related]

  • 9. Repurposing of FDA-approved antivirals, antibiotics, anthelmintics, antioxidants, and cell protectives against SARS-CoV-2 papain-like protease.
    Kandeel M, Abdelrahman AHM, Oh-Hashi K, Ibrahim A, Venugopala KN, Morsy MA, Ibrahim MAA.
    J Biomol Struct Dyn; 2021 Sep; 39(14):5129-5136. PubMed ID: 32597315
    [Abstract] [Full Text] [Related]

  • 10. Pharmacoinformatics approach based identification of potential Nsp15 endoribonuclease modulators for SARS-CoV-2 inhibition.
    Savale RU, Bhowmick S, Osman SM, Alasmary FA, Almutairi TM, Abdullah DS, Patil PC, Islam MA.
    Arch Biochem Biophys; 2021 Mar 30; 700():108771. PubMed ID: 33485847
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Discovery of Potent SARS-CoV-2 Inhibitors from Approved Antiviral Drugs via Docking and Virtual Screening.
    Chtita S, Belhassan A, Aouidate A, Belaidi S, Bouachrine M, Lakhlifi T.
    Comb Chem High Throughput Screen; 2021 Mar 30; 24(3):441-454. PubMed ID: 32748740
    [Abstract] [Full Text] [Related]

  • 14. Identification of chymotrypsin-like protease inhibitors of SARS-CoV-2 via integrated computational approach.
    Khan SA, Zia K, Ashraf S, Uddin R, Ul-Haq Z.
    J Biomol Struct Dyn; 2021 Apr 30; 39(7):2607-2616. PubMed ID: 32238094
    [Abstract] [Full Text] [Related]

  • 15. Insilico drug repurposing using FDA approved drugs against Membrane protein of SARS-CoV-2.
    Peele KA, Kumar V, Parate S, Srirama K, Lee KW, Venkateswarulu TC.
    J Pharm Sci; 2021 Jun 30; 110(6):2346-2354. PubMed ID: 33684397
    [Abstract] [Full Text] [Related]

  • 16. A systematic drug repurposing approach to identify promising inhibitors from FDA-approved drugs against Nsp4 protein of SARS-CoV-2.
    Chakraborty J, Maity A, Sarkar H.
    J Biomol Struct Dyn; 2023 Feb 30; 41(2):550-559. PubMed ID: 34844509
    [Abstract] [Full Text] [Related]

  • 17. Identification of promising drug candidates against NSP16 of SARS-CoV-2 through computational drug repurposing study.
    Vijayan V, Pant P, Vikram N, Kaur P, Singh TP, Sharma S, Sharma P.
    J Biomol Struct Dyn; 2021 Oct 30; 39(17):6713-6727. PubMed ID: 32741322
    [Abstract] [Full Text] [Related]

  • 18. In-silico drug repurposing and molecular dynamics puzzled out potential SARS-CoV-2 main protease inhibitors.
    Ibrahim MAA, Abdelrahman AHM, Hegazy MF.
    J Biomol Struct Dyn; 2021 Sep 30; 39(15):5756-5767. PubMed ID: 32684114
    [Abstract] [Full Text] [Related]

  • 19. Vitamin D is a potential inhibitor of COVID-19: In silico molecular docking to the binding site of SARS-CoV-2 endoribonuclease Nsp15.
    Shalayel MH, Al-Mazaideh GM, Aladaileh SH, Al-Swailmi FK, Al-Thiabat MG.
    Pak J Pharm Sci; 2020 Sep 30; 33(5):2179-2186. PubMed ID: 33824127
    [Abstract] [Full Text] [Related]

  • 20. Exploring potential inhibitor of SARS-CoV2 replicase from FDA approved drugs using insilico drug discovery methods.
    Chandra A, Gurjar V, Ahmed MZ, Alqahtani AS, Qamar I, Singh N.
    J Biomol Struct Dyn; 2022 Aug 30; 40(12):5507-5514. PubMed ID: 33491573
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.